Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising enhancements across different clinical and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, additional reputable alternate for therapeutic use